| Accession |
PRJCA020915 |
| Title |
head and neck squamous cell carcinoma |
| Relevance |
Medical |
| Data types |
Phenotype or Genotype
|
| Organisms |
Homo sapiens
|
| Description |
Chemoimmunotherapy has shown promising results with locally advanced head and neck squamous cell carcinoma (LAHNSCC); however, markers accurately predicting its efficacy and survival remain elusive. To generate and validate a pathomics signature and immunoscore-based model for prediction of chemoimmunotherapy response and progression-free survival (PFS) among patients with LAHNSCC. |
| Sample scope |
Multiisolate |
| Release date |
2023-10-31 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
cheng
xiao (21218159@zju.edu.cn)
|
| Organization |
The First Affiliated Hospital, Zhejiang University School of Medicine |
| Submission date |
2023-10-31 |
